Inventor
NABIROCHKIN SERGUEI
FR52 patents
⚠️ This page may combine multiple inventors who share the name “NABIROCHKIN SERGUEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARNEXT
41 patentsUS9566275B2Feb 14, 2017
Compositions for treating CMT and related disorders
PHARNEXT13 citations93
US9427436B1Aug 30, 2016
Compositions for treating CMT and related disorders
PHARNEXT14 citations93
US9393241B2Jul 19, 2016
Compositions for treating CMT and related disorders
PHARNEXT14 citations93
US9241933B2Jan 26, 2016
Compositions for treating amyotrophic lateral sclerosis
PHARNEXT16 citations92
US8865769B2Oct 21, 2014
Baclofen and acamprosate based therapy of neurological disorders
PHARNEXT15 citations92
US8741886B2Jun 3, 2014
Baclofen and acamprosate based therapy of neurological disorders
PHARNEXT20 citations92
US9248111B2Feb 2, 2016
Therapeutic approaches for treating parkinson's disease
PHARNEXT6 citations84
US9636316B2May 2, 2017
Baclofen and acamprosate based therapy of neurological disorders
PHARNEXT5 citations83
US9144558B2Sep 29, 2015
Baclofen and acamprosate based therapy of neurological disorders
PHARNEXT8 citations83
US10300015B2May 28, 2019
Stable oral solutions for combined API
PHARNEXT8 citations82
US10905686B2Feb 2, 2021
Compositions for treating CMT and related disorders
PHARNEXT1 citations73
US10583135B2Mar 10, 2020
Compositions for treating CMT and related disorders
PHARNEXT1 citations73
US10463640B2Nov 5, 2019
Therapeutic approaches for treating CMT and related disorders
PHARNEXT1 citations73
US10441558B2Oct 15, 2019
Therapeutic approaches for treating CMT and related disorders
PHARNEXT1 citations73
US10342784B2Jul 9, 2019
Compositions for treating amyotrophic lateral sclerosis
PHARNEXT2 citations73
US10342768B2Jul 9, 2019
Therapeutic approaches for treating Parkinson's disease
PHARNEXT2 citations73
US10322101B2Jun 18, 2019
Therapeutic approaches for treating CMT and related disorders
PHARNEXT2 citations73
US10092554B2Oct 9, 2018
Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
PHARNEXT3 citations73
US10045971B2Aug 14, 2018
Compositions for treating amyotrophic lateral sclerosis
PHARNEXT3 citations73
US10010515B2Jul 3, 2018
Therapeutic approaches for treating Parkinson's disease
PHARNEXT3 citations73
US10004744B2Jun 26, 2018
Therapeutic approaches for treating Parkinson's disease
PHARNEXT3 citations73
US9387206B2Jul 12, 2016
Therapeutic approaches for treating Alzheimer's disease
PHARNEXT3 citations73
US10434109B2Oct 8, 2019
Compositions for treating neurological disorders
PHARNEXT2 citations72
US9931326B2Apr 3, 2018
Composition comprising torasemide and baclofen for treating neurological disorders
PHARNEXT5 citations72
US9867837B2Jan 16, 2018
Compositions for treating neurological disorders
PHARNEXT3 citations71
US10940147B2Mar 9, 2021
Early treatment of CMT disease
PHARNEXT1 citations69
US10383870B2Aug 20, 2019
Early treatment of CMT disease
PHARNEXT1 citations69
US11672796B2Jun 13, 2023
Compositions for treating CMT and related disorders
PHARNEXT0 citations63
US11576908B2Feb 14, 2023
Compositions for treating CMT and related disorders
PHARNEXT0 citations63
US10905672B2Feb 2, 2021
Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders
PHARNEXT1 citations62
US10849851B2Dec 1, 2020
Stable oral solutions for combined API
PHARNEXT1 citations60
US12226413B2Feb 18, 2025
Early treatment of CMT disease
PHARNEXT0 citations59
US10350195B2Jul 16, 2019
Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function
PHARNEXT1 citations59
US10682342B2Jun 16, 2020
Compositions for treating amyotrophic lateral sclerosis
PHARNEXT0 citations52
US10596160B2Mar 24, 2020
Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
PHARNEXT0 citations52
US10265304B2Apr 23, 2019
Nootropic compositions for improving memory performance
PHARNEXT0 citations52
US9945876B2Apr 17, 2018
Diagnostic tools for charcot-marie-tooth disease
PHARNEXT0 citations52
US9789098B2Oct 17, 2017
Nootropic compositions for improving memory performance
PHARNEXT0 citations52
US9597297B2Mar 21, 2017
Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
PHARNEXT1 citations52
US9545389B2Jan 17, 2017
Baclofen and acamprosate based therapy of macular degeneration disorders
PHARNEXT1 citations52
US10874644B2Dec 29, 2020
Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function
PHARNEXT0 citations49
COHEN DANIEL
9 patentsUS8992891B2Mar 31, 2015
Therapeutic approaches for treating CMT and related disorders
COHEN DANIEL19 citations92
US8716269B2May 6, 2014
Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
COHEN DANIEL21 citations92
US8809302B2Aug 19, 2014
Therapeutic approaches for treating alzheimer'S disease
COHEN DANIEL15 citations84
US9820978B2Nov 21, 2017
Treatment of cerebral ischemia
COHEN DANIEL3 citations71
US8552041B2Oct 8, 2013
Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
COHEN DANIEL4 citations62
US11291670B2Apr 5, 2022
Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis
COHEN DANIEL0 citations59
US9494605B2Nov 15, 2016
Diagnostic tools for charcot-marie-tooth disease
COHEN DANIEL0 citations52
US8642566B2Feb 4, 2014
Therapeutic approaches for treating neuroinflammatory conditions
COHEN DANIEL0 citations52
US9493834B2Nov 15, 2016
Method for detecting a panel of biomarkers
COHEN DANIEL1 citations49
Showing the top 50 of 52 patents by PatentIndex Score.